This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Pharma Stocks
Pharma Stocks collects four articles on big pharma movers, from Novo Nordisk to Merck, highlighting value, growth angles, and dividend potential to help smarter investing.
42 articles
Lilly Just Announced Fantastic News for Shareholders
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...
AbbVie’s Latest Results Reveal Growth Trend Investors Should Watch
AbbVie’s latest results reveal more than a quarterly beat. This article breaks down the growth engines behind the imp...
Lilly World's Best-Selling Drug: Is the Stock a Buy Now?
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Reason Lilly Stock Still: A Buy Case for 2026 and Beyond
Lilly stock has faced pressure, but one key driver could keep it in buy territory. This article unpacks the core reas...
Pfizer Stock Doing Something: A Turning Point for Investors
Pfizer stock is signaling a shift after years of underperformance. This article breaks down what’s changing, why it m...
Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Novo Nordisk Stock Outlook 2026–2030: Forecasts and Risks
Analysts project a multi-year path for novo nordisk (nvo) stock, supported by strong product momentum but tempered by...
Assertio (ASRT) 2025 Earnings: What Investors Watch
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
GLP-1s Cure Hunger More, Study Finds Broad Impact
A sweeping real-world study of roughly 600,000 GLP-1 users finds cravings for cigarettes, alcohol, and other addictio...
Forget Teva: This Dividend Top Dog Is Real Value
Turnaround stories can spark excitement, but income-focused investors should seek a true dividend top dog. This artic...
Why Shares Novo Nordisk Stock Sank This Week: Key Factors
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...